Skip to main content

Table 1 Baseline characteristics of the propensity-matched patients of the Redo-TAVI and Redo-AVR group

From: Propensity matched analysis of longterm outcomes following transcatheter based aortic valve implantation versus classic aortic valve replacement in patients with previous cardiac surgery

  All patients Propensity-matched patients
  Redo-TAVI (n = 52) Redo-AVR (n = 167)   Redo-TAVI (n = 40) Redo-AVR (n = 40)  
Variables No. (%) No. (%) p value No. (%) No. (%) p value
Age (years) 82 ± 5 72 ± 9 0.07 81 ± 4 80 ± 3 >0.99
Log EuroSCORE|| 25 ± 5 17 ± 2 0.11 24 ± 6 19 ± 6 0.58
STS risk score 11 ± 4 9 ± 2 0.07 11.1 ± 2.8 10.4 ± 3 0.65
Male 31 (60) 92 (55) 0.44 29 (73) 29 (73) >0.99
Arterial hypertension 22 (42) 106 (63) 0.14 16 (40) 18 (45) 0.69
Pulmonary hypertension 16 (31) 72 (43) 0.24 5 (13) 5 (13) >0.99
Diabetes 20 (38) 43 (26) 0.42 17 (42) 14 (35) 0.54
CAD 45 (87) 42 (25) 0.03 33 (83) 30 (75) 0.46
COPD§ 19 (36) 37 (22) 0.67 9 (23) 8 (20) 0.81
Chronic renal failure* 30 (58) 21 (12) 0.05 20 (50) 16 (40) 0.43
Peripheral vascular disease 23 (44) 24 (14) 0.04 13 (33) 11 (27) 0.43
Cerebrovascular disease 20 (38) 31 (18) 0.07 9 (23) 8 (20) 0.81
LV-EF < 30 21 (40) 39 (23) 0.06 9 (23) 9 (23) >0.99
Mean ejection fraction 39 ± 18 44 ± 14 0.62 48 ± 14 47 ± 12 0.77
Aortic valve area (cm) 0.65 ± 0.24 0.5 ± 0.31 0.46 0.63 ± 0.29 0.68 ± 0.31 0.65
Mean pressure gradient (echo; mmHg) 59 ± 18 57 ± 14 0.59 57 ± 21 51 ± 16 0.56
Peak to peak gradient (invasive; mmHg) 67 ± 27 70 ± 35 0.55 69 ± 36 65 ± 34 0.58
Mean time interval between initialand current cardiac procedure (years) 7 ± 4 11 ± 8 0.60 7 ± 5 8 ± 6 0.78
  1. CAD = coronary artery disease; §COPD = chronic obstructive pulmonary disease; ||EuroSCORE = European system for cardiac risk evaluation; LV-EF = left ventricular ejection fraction.